LABD vs. XLV
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and XLV (State Street Health Care Select Sector SPDR ETF) are both exchange-traded funds - LABD is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (-300%), while XLV is a Health & Biotech Equities fund tracking the Health Care Select Sector Index. Both are passively managed. Over the past 10 years, LABD returned -56.11%/yr vs 9.20%/yr for XLV. At a correlation of -0.59, they often move in opposite directions. LABD charges 1.06%/yr vs 0.08%/yr for XLV.
Performance
LABD vs. XLV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -29.83% return, which is significantly lower than XLV's -4.29% return. Over the past 10 years, LABD has underperformed XLV with an annualized return of -56.11%, while XLV has yielded a comparatively higher 9.20% annualized return.
LABD
- 1D
- -4.73%
- 1M
- 4.70%
- YTD
- -29.83%
- 6M
- -31.22%
- 1Y
- -80.27%
- 3Y*
- -49.85%
- 5Y*
- -41.45%
- 10Y*
- -56.11%
XLV
- 1D
- 0.79%
- 1M
- 1.95%
- YTD
- -4.29%
- 6M
- -4.06%
- 1Y
- 12.89%
- 3Y*
- 5.98%
- 5Y*
- 5.55%
- 10Y*
- 9.20%
LABD vs. XLV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -29.83% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -70.80% | -6.26% | -75.67% |
XLV State Street Health Care Select Sector SPDR ETF | -4.29% | 14.50% | 2.47% | 2.07% | -2.08% | 26.04% | 13.30% | 20.45% | 6.28% | 21.77% |
Correlation
The correlation between LABD and XLV is -0.54, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.54 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.53 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.52 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.57 |
Correlation (All Time) Calculated using the full available price history since May 29, 2015 | -0.59 |
The correlation between LABD and XLV has been stable across timeframes, ranging from -0.59 to -0.52 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. XLV — Risk / Return Rank
LABD
XLV
LABD vs. XLV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABD | XLV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.94 | ||
| Sortino ratioReturn per unit of downside risk | -3.64 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 1.16 | -0.41 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 1.24 | -2.20 |
| Martin ratioReturn relative to average drawdown | -1.31 | 2.99 | -4.30 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LABD | XLV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.06 | 0.88 | -1.94 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.43 | 0.38 | -0.81 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.59 | 0.56 | -1.14 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.54 | 0.46 | -1.00 |
Drawdowns
LABD vs. XLV - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for LABD and XLV.
Loading charts...
Drawdown Indicators
| LABD | XLV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -39.17% | -60.82% |
Max Drawdown (1Y)Largest decline over 1 year | -83.21% | -10.47% | -72.74% |
Max Drawdown (3Y)Largest decline over 3 years | -95.31% | -17.11% | -78.20% |
Max Drawdown (5Y)Largest decline over 5 years | -98.24% | -17.11% | -81.13% |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | -28.40% | -71.58% |
Current DrawdownCurrent decline from peak | -99.99% | -7.52% | -92.47% |
Average DrawdownAverage peak-to-trough decline | -90.92% | -7.12% | -83.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.36% | 4.32% | +57.04% |
Volatility
LABD vs. XLV - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 27.46% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 4.10%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | XLV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.46% | 4.10% | +23.36% |
Volatility (6M)Calculated over the trailing 6-month period | 61.67% | 10.24% | +51.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.77% | 14.67% | +61.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.26% | 14.69% | +81.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.93% | 16.55% | +79.38% |
LABD vs. XLV - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than XLV's 0.08% expense ratio.
Dividends
LABD vs. XLV - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 6.45%, more than XLV's 1.70% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 6.45% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% | 0.00% | 0.00% | 0.00% |
XLV State Street Health Care Select Sector SPDR ETF | 1.70% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
LABD and XLV have a correlation of -0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (27.46%) compared to XLV (4.10%). In terms of maximum drawdown, LABD dropped -99.99% vs XLV's -39.17%.
On 10-year performance, XLV leads with 9.20% vs -56.11% for LABD. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 4.10%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XLV has performed better with a 9.20% return vs -56.11%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 1.06% for LABD.
LABD has the higher dividend yield at 6.45%, compared with 1.70% for XLV.
LABD is categorized as Leveraged Equities, while XLV is Health & Biotech Equities. LABD tracks S&P Biotechnology Select Industry Index (-300%), while XLV tracks Health Care Select Sector Index. They also come from different issuers: Direxion and State Street. Their fees differ too: 1.06% for LABD and 0.08% for XLV.
XLV currently has the higher Sharpe Ratio (0.88 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and XLV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer